Bortezomib
NDC 68001-541, Bortezomib, injection, powder, lyophilized, for solution, from BluePoint Laboratories.
- Product NDC
- 68001-541
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209622
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-541 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB3.5 mg/3.5mL
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-541-36 | 68001054136 | 1 VIAL, SINGLE-USE in 1 CARTON (68001-541-36) / 3.5 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c6b620c6-f3d6-4ff3-b46a-50a66e6d41ddMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-541
Use it
Look up 68001-541 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-541 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-541. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.